ATE291740T1 - Verfahren für die bestimmung von plättchen aktivierendem faktor - Google Patents

Verfahren für die bestimmung von plättchen aktivierendem faktor

Info

Publication number
ATE291740T1
ATE291740T1 AT02730840T AT02730840T ATE291740T1 AT E291740 T1 ATE291740 T1 AT E291740T1 AT 02730840 T AT02730840 T AT 02730840T AT 02730840 T AT02730840 T AT 02730840T AT E291740 T1 ATE291740 T1 AT E291740T1
Authority
AT
Austria
Prior art keywords
paf
plale
determination
mass spectrometry
highly sensitive
Prior art date
Application number
AT02730840T
Other languages
English (en)
Inventor
Yasushi Kanai
Yujiro Hayashi
Norio Onuma
Hiroshi Miyazaki
Original Assignee
Daiichi Suntory Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Suntory Pharma Co Ltd filed Critical Daiichi Suntory Pharma Co Ltd
Application granted granted Critical
Publication of ATE291740T1 publication Critical patent/ATE291740T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT02730840T 2001-05-31 2002-05-31 Verfahren für die bestimmung von plättchen aktivierendem faktor ATE291740T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001164982 2001-05-31
PCT/JP2002/005369 WO2002097435A2 (en) 2001-05-31 2002-05-31 Assay method for platelet-activating factor

Publications (1)

Publication Number Publication Date
ATE291740T1 true ATE291740T1 (de) 2005-04-15

Family

ID=19007715

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02730840T ATE291740T1 (de) 2001-05-31 2002-05-31 Verfahren für die bestimmung von plättchen aktivierendem faktor

Country Status (10)

Country Link
US (1) US20040175776A1 (de)
EP (1) EP1390759B1 (de)
JP (1) JP4087334B2 (de)
AT (1) ATE291740T1 (de)
AU (1) AU2002302977A1 (de)
BR (1) BR0205443A (de)
DE (1) DE60203388T2 (de)
ES (1) ES2239230T3 (de)
NO (1) NO20030461D0 (de)
WO (1) WO2002097435A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008280806B2 (en) * 2007-07-26 2014-12-11 Phenomenome Discoveries Inc. Methods for the diagnosis, risk assessment, and monitoring of autism spectrum disorders
JP5351076B2 (ja) * 2010-02-26 2013-11-27 杏林製薬株式会社 オンライン固相抽出による生体試料液中薬剤成分の定量方法
JP5982676B2 (ja) * 2011-02-28 2016-08-31 学校法人 いわき明星大学 抗paf活性を有するビオチニル化ペプチド化合物
HK1247283A1 (zh) * 2015-03-02 2018-09-21 科罗纳里康赛普茨有限责任公司 用於peg代谢物及peg分解产物检测的化合物及方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78246B (de) * 1981-01-23 1984-09-26 Ciba Geigy Ag
DE3445950A1 (de) * 1984-12-17 1986-06-19 A. Nattermann & Cie GmbH, 5000 Köln Verfahren zur isolierung von lysophosphatidylcholin-freiem phosphatidylcholin aus ei-pulver
FR2630006B1 (fr) * 1988-04-18 1991-07-19 Pasteur Institut Nouvelle preparation de recepteurs du paf et nouvelle methode de dosage du paf

Also Published As

Publication number Publication date
BR0205443A (pt) 2003-07-08
JP4087334B2 (ja) 2008-05-21
EP1390759A2 (de) 2004-02-25
WO2002097435A2 (en) 2002-12-05
EP1390759B1 (de) 2005-03-23
NO20030461D0 (no) 2003-01-29
AU2002302977A1 (en) 2002-12-09
ES2239230T3 (es) 2005-09-16
JP2004527770A (ja) 2004-09-09
DE60203388T2 (de) 2006-04-13
WO2002097435A3 (en) 2003-09-04
DE60203388D1 (de) 2005-04-28
US20040175776A1 (en) 2004-09-09

Similar Documents

Publication Publication Date Title
DE60239968D1 (de) Sche
DE60023539D1 (de) Immunologischer nachweis von rna:dna hybriden auf mikroarrays
MXPA02010106A (es) Determinacion de suficiencia de volumen de muestra en dispositivos biosensores.
ATE428924T1 (de) Inline-testeinrichtung und verfahren zur verwendung
MX2010000971A (es) Sistema y metodos que determinan concentracion de analito utilizando amperometria resuelta en tiempo.
ATE295541T1 (de) Verfahren und vorrichtung zur untersuchung von wirksstoffskandidaten und zur bestimmung ihrer pharmakokinetischen parametern
CY1111229T1 (el) Μεθοδος προσδιορισμου ρευματοειδους αρθριτιδας με μετρηση αντι-ccp και ιντερλευκλινης 6
DE59813993D1 (de) Analytisches messgerät mit stechhilfe
CA2322858A1 (en) Detection of analytes by fluorescent lanthanide chelates
ATE393914T1 (de) Nachweis von biomolekülen unter verwendung poröser biosensoren und raman-spektroskopie
DK1311707T3 (da) Massespektroskopisk analyse af biopolymerer
WO2005080602A3 (en) Immunological detection of rna:dna hybrids on microarrays
BRPI0610092A2 (pt) mÉtodos para a detecÇço de um analito e de um Ácido nucleico em uma amostra, e para sintetizaÇço de uma molÉcula de Ácido nucleico ou de anÁlago de Ácido nucleico, kit reagente, usos do mesmo, de um composto, e de um mÉtodo, molÉcula de Ácido nucleico ou de anÁlogo de Ácido nucleico, produto de metalizaÇço, produto associado, e, composto
DE602006011756D1 (de) Komplexformierungs- und -trennungsverfahren
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
DE602005014386D1 (de) Verwendung von cyfra 21-1 und osteopontin als marker für kolorektalkarzinome
WO2004042403A3 (en) Methods, device and instrument for detection of analytes
DE60133558D1 (de) Direkte bestimmung des quotients von analyt- zu referenzmolekülen
WO2002099381A3 (en) A single-cell biosensor for the measurement of gpcr ligands in a test sample
DE60203388D1 (de) Verfahren für die bestimmung von plättchen aktivierendem faktor
ATE363069T1 (de) Bestimmung der genauigkeit eines probevolumens in biosensoren
CA2586654A1 (en) Use of asc as a marker for colorectal cancer
DE602004031571D1 (de) Enzymhemmungsimmunverfahren
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
DE602005015627D1 (de) Verfahren zur messung von proinsulin und c-peptid sowie kit dafür

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties